详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Diagnosis and treatment of cholangiocarcinoma: A consensus from surgical specialists of China

106| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Cancer Institute and Hospital, Chinese Academy of Medical Sciences [2]Chinese PLA General Hospital [3]Eastern Hepatobiliary Surgery Hospital of Second Military Medical University [4]Sun Yat-sen University Cancer Center [5]Daping Hospital of Third Military Medical University [6]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [7]Fujian Medical University Union Hospital [8]Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology [9]Shengjing Hospital of China Medical University [10]Anhui Provincial Hospital [11]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [12]Hunan Provincial People’s Hospital [13]Taihe Hospital Affiliated to Hubei University of Medicine [14]Peking University People’s Hospital [15]West China Hospital, Sichuan University [16]The Second Affiliated Hospital of Xi’an Jiao Tong University [17]The First Affiliated Hospital, Sun Yat-sen University [18]First Affiliated Hospital of Kunming Medical University [19]The First Affiliated Hospital of Bengbu Medical College [20]The First Affiliated Hospital of Harbin Medical University [21]The First Affiliated Hospital of Xi’an Jiao Tong University [22]Chinese PLA General Hospital [23]Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine [24]Tangdu Hospital of Fourth Military Medical University [25]Chinese PLA General Hospital [26]The First Affiliated Hospital of Xi’an Jiao Tong University [27]Peking Union Medical College Hospital [28]Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology [29]Qilu Hospital of Shandong University [30]The First Affiliated Hospital, Sun Yat-sen University [31]The First Affiliated Hospital of Guangxi Medical University [32]Nanjing Drum Tower Hospital [33]The First Affiliated Hospital of Jilin University [34]Fujian Provincial Hospital [35]Xiangya Hospital of Central South University [36]The First Affiliated Hospital of Nanchang University [37]Nanjing Drum Tower Hospital [38]Beijing Cancer Hospital [39]Southwest Hospital of Third Military Medical University [40]Anhui Provincial Hospital [41]Eastern Hepatobiliary Surgery Hospital of Second Military Medical University [42]Shenzhen People’s Hospital [43]West China Hospital, Sichuan University [44]The First Affiliated Hospital of Fujian Medical University [45]Tongji Hospital, Tongji Medical [46]Huazhong University of Science and Technology [47]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [48]The First Affiliated Hospital of Wenzhou Medical University [49]The First Affiliated Hospital of Zhengzhou University [50]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [51]Eastern Hepatobiliary Surgery Hospital of Second Military Medical University [52]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [53]Fujian Provincial Cancer Hospital [54]Eastern Hepatobiliary Surgery Hospital of Second Military Medical University

出处：

DOI：

ISSN：

摘要：

Cholangiocarcinoma refers to malignant tumors that develop in epithelial lining of biliary system, and it is divided into two categories according to tumor location, intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC). ICC occurs from the epithelial cells of the intrahepatic bile duct, its branches and interlobular biliary tree; and ECC is divided into hilar cholangiocarcinoma and distal cholangiocarcinoma by the circumscription at the confluence of cystic duct and the common hepatic duct. During the past 10 years, the incidence of cholangiocarcinoma kept increasing, in which ICC accounts for 20%-25%, hilar cholangiocarcinoma about 50%-60%, and distal extrahepatic cholangiocarcinoma about 20%-25%([1-3]). The guidelines on diagnosis and treatment of cholangiocarcinoma have been established and revised several times in past 10 years. In 2010, ICC was separated from hepatic cancer by the 7th version of TNM Staging System (American Joint Committee on Cancer, AJCC). In response to this new situation, it is necessary to develop a consensus on diagnosis and treatment of cholangiocarcinoma in China. This draft aims at summarizing the views on the diagnosis and treatment of cholangiocarcinoma of the surgical experts from more than 30 medical centers in China, and laying down a foundation for establishing a guideline on diagnosis and treatment of cholangiocarcinoma in China.

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2014]版：

大类 | 4 区医学

小类 | 4 区生化与分子生物学

最新[2023]版：

无

JCR分区：

出版当年[2014]版：

Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

最新[2023]版：

无

影响因子： 0 最新[2023版] 0 最新五年平均 0.834 出版当年[2014版] 0.749 出版当年五年平均 0.779 出版前一年[2013版] 0.838 出版后一年[2015版]

第一作者：

第一作者机构： [1]Cancer Institute and Hospital, Chinese Academy of Medical Sciences

通讯机构： [*1]Department of Surgery Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan 430030, China

推荐引用方式(GB/T 7714)：

APA：

MLA：